Jerry Nick, MD
National Jewish Health
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Jerry Nick, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06262282 · Mycobacteriophage Treatment of Non-tuberculosis MycobacteriaNational Jewish Health · enrolling by invitation · Cystic Fibrosis, Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection · principal investigator
- N/ANCT05822102 · Simultaneous quanTification of Elexacaftor/tezAcaftor/Ivacaftor Via Reverse Phase High Performance liquiD chromatographYNational Jewish Health · unknown · Cystic Fibrosis · principal investigator
- Ph2NCT03597347 · Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial InfectionSavara Inc. · terminated · Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) · principal investigator
- Ph2NCT01685801 · Pilot Study Testing the Effect of Ivacaftor on Lung Function in Subjects With Cystic Fibrosis and Residual CFTR FunctionVertex Pharmaceuticals Incorporated · completed · Cystic Fibrosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.